False Positives in PCR Tests for COVID-19

The prevalence of misinformation coming from the most trusted form of coronavirus test may be more significant than previously thought.

Three types of tests are used to diagnose current, active infection by the COVID-19 virus: PCR tests, rapid molecular tests, and antigen tests. PCR tests are generally held to be the most accurate, and are often used as the “gold standard” against which the other types of tests are measured.

Medical and public health professionals have generally treated positive results from PCR-based tests for COVID-19 as if they are completely reliable. We’re told that if we test positive, then we are infected with the virus, and that positive results in PCR tests are rarely if ever inaccurate. In fact, however, false positives occur in PCR tests for COVID-19 often enough to be a significant problem.

What is a PCR test? PCR stands for polymerase chain reaction. This is a chemical reaction that repeatedly duplicates certain targeted segments of the virus’s RNA, until there’s enough of it to be detected. The targeted segments are carefully selected to be unique to the COVID-19 virus, and thus absent from other genetic material –  human tissues or other pathogens – that might be present in human respiratory samples. This means that with a well-designed test, we can be highly certain that any reaction and duplication occurs only with genetic material from the COVID-19 virus, and that no false positives are produced as a result of the test reacting with some other biological material.

However, in practice, there are other ways that false positives can arise. Samples can get mixed up, software glitches can produce erroneous interpretations of test results, and mistakes can be made when entering or communicating data. Because of the high degree of duplication of the targeted genetic segments by PCR tests (which, depending on the number of duplication cycles run, can multiply an initially low concentration of these segments by a billion times or more), trace amounts of contamination can produce false-positive results that are indistinguishable from true positive results. Such minute levels of contamination can be extremely hard to control. False positives from contamination have been regularly documented in diagnostic PCR tests, including in the most highly regarded laboratories.

In this article, I define the false-positive rate for COVID-19 PCR tests as the percentage of samples from uninfected individuals that incorrectly yield a positive test result. We have three lines of evidence indicating that COVID-19 PCR tests have a low but significant false-positive rate. Some of this is derived from studies called external quality assessments, which assess the accuracy of diagnostic tests conducted by laboratories by providing participating labs with blind sets of positive and negative samples to analyze. From the results for the negative samples, we can calculate false-positive rates.

When we began this work in March, no external quality assessments had yet been completed for COVID-19 PCR tests. So we reviewed 43 external quality assessments of PCR tests for other viruses similar to COVID-19, and found that half of these assessments produced false-positive rates between 0.8 and 4.0 percent, with a median value of 2.3 percent.

Since then, results have become available from a few external quality assessments of COVID-19 tests. These have false-positive rates ranging from under 0.4 to 0.7 percent.

Our third line of evidence is from real-world uses of COVID-19 PCR tests wherein positive results were checked with additional tests. In most of these, the false-positive rate was between 0.2 and 0.9 percent.

Evidence for a Significant False Positive Rate (FPR) in PCR Tests for COVID-19

Data from External Quality Assessments of PCR tests for other RNA viruses • FPR usually between 0.8% and 4.0%
• Median = 2.3%; Pooled mean = 3.2%
Data from External Quality Assessments of PCR tests for COVID-19 • FPR between <0.4% and 0.7%
• Pooled mean = 0.6%
Data from actual use of PCR tests for COVID-19 • FPR usually between 0.2% and 0.9%

 

These rates may sound low, but when the rate of infection is low, even a small false-positive rate can greatly diminish the reliability of positive test results. For example, consider the scenario diagrammed below, in which 100,000 people are tested, with 1 percent, or 1,000 of them, being infected. If the false-negative rate is 25 percent, a typical estimate from the scientific literature on COVID-19, and the false positive rate is 0.5 percent, a reasonable estimate from our data, then a quarter of the 1,000 samples from infected individuals – that is, 250 samples – will be false negatives, and the rest will be true positives.

The false positives and true negatives are calculated in the diagram in the same way. In the lower part of the diagram, these figures are used to calculate that the percentage of negative results that are false is 0.25 percent, and the percentage of positive results that are false is nearly 40 percent.
cohen 1

So, with a 1-percent infection rate in the test population, a false-positive rate of only 0.5 percent leads to nearly 40 percent of the positive results being wrong. And although the false-negative rate is 50 times higher than the false-positive rate, it is nevertheless much more likely (nearly 160 times more likely) that a positive result will be wrong than a negative result will be wrong. Notice that this doesn’t align with what most health authorities have been telling us, which is that we can trust a positive PCR result as proof that we’re definitely infected, but that we can’t rely on a negative result as proof that we’re not infected. In fact, just the opposite is true – negative results are reliable and positive results are not – when the infection rate is low.

So, how often is the infection rate low enough for false positives to be a problem? The next slide shows the test positivity (what fraction of people tested received a positive result) in New York State from late March to September, and the percentage of positive results that would be wrong, assuming the same false-negative and false-positive rates of 25 and 0.5 percent. As you can see, when the disease was spiking, at the beginning of this period, there would have been very few false positives, and positive results could be trusted. However, as the infection rate and test positivity fell, in May, an increasingly large portion of the positive results would be wrong. Now that new cases in the U.S. are exceeding 100,000 daily, an unprecedented figure, the pendulum appears to be swinging the other way.
Cohen 2

However, this data, doesn’t tell the whole story. Individuals who exhibit COVID-19 symptoms are more likely to be infected than individuals who have no symptoms. Thus, people who are tested because they have symptoms will likely have a higher test positivity, especially during an outbreak; for these people, positive results will be more reliable, more likely to be true positives, than the average data would indicate.

On the other hand, people who do not have symptoms will be less likely to be infected and will have a lower test positivity. For these people, positive results will be more likely to be wrong than the averages indicate. Thus, even during a major outbreak, there may be portions of the test population consisting of individuals that are mostly or entirely asymptomatic – individuals tested in nursing homes, homeless shelters, prisons, or other congregate living situations; patients tested automatically upon hospital admission or prior to surgeries; athletes tested as a requirement for participation in sports activities; etc. – for whom positive PCR results may likely be false.

Programming Note: Listen to Andrew Cohen report this story live today during Talk Ten Tuesdays, 10-10:30 a.m. EST.

Facebook
Twitter
LinkedIn

Andrew N. Cohen, PhD

Andrew Cohen is the Director and Lead Scientist at the Center for Research on Aquatic Bioinvasions or CRAB. CRAB is known to conduct scientific research to protect biological invasions on the local, state, and federal level. Cohen is currently working on ballast water regulations and how it can transfer both human and animal diseases.

Related Stories

You Down with CfC?

You Down with CfC?

Anyone who has worked within the scope of hospital case/utilization management for any period of time has heard of the Centers for Medicare & Medicaid

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.

December 3, 2025

Proactive Denial Management: Data-Driven Strategies to Prevent Revenue Loss

Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.

November 25, 2025
Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.

September 24, 2025

Trending News

Featured Webcasts

Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue

Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.

January 29, 2026

AI in Claims Auditing: Turning Compliance Risks into Defensible Systems

As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.

January 13, 2026
Surviving Federal Audits for Inpatient Rehab Facility Services

Surviving Federal Audits for Inpatient Rehab Facility Services

Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.

November 13, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24